[1]宋锦文,王志宏,王新林,等.导管碎栓联合局部灌注瑞替普酶溶栓治疗高危肺动脉栓塞[J].介入放射学杂志,2014,(10):870-873.
 SONG Jin wen,WANG Zhi hong,WANG Xin lin,et al.Transcatheter thrombus breaking combined with local infusion of reteplase for the treatment of severe pulmonary thromboembolism[J].journal interventional radiology,2014,(10):870-873.
点击复制

导管碎栓联合局部灌注瑞替普酶溶栓治疗高危肺动脉栓塞 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2014年10期
页码:
870-873
栏目:
血管介入
出版日期:
2014-10-25

文章信息/Info

Title:
Transcatheter thrombus breaking combined with local infusion of reteplase for the treatment of severe pulmonary thromboembolism
作者:
宋锦文 王志宏 王新林 张经国 魏 旋 刘彩霞
Author(s):
SONG Jin wen WANG Zhi hong WANG Xin lin ZHANG Jing guo WEI Xuan LIU Cai xia.
Department of Interventional Radiology, Lanzhou General Hospital of Lanzhou Military Region, Lanzhou, Gansu Province 730050, China
关键词:
【关键词】 高危肺栓塞 瑞替普酶 肺动脉 溶栓术
文献标志码:
A
摘要:
【摘要】 目的 探讨导管碎栓联合局部灌注瑞替普酶溶栓治疗高危肺动脉栓塞的疗效及安全性。方法 高危肺动脉栓塞患者26例,经肺动脉内导管碎栓和局部灌注瑞替普酶溶栓治疗, 观察处理前后肺循环改善情况,分析心肺血流动力学的改变。结果 26例高危肺栓塞患者,术前平均肺动脉压、动脉血氧分压和血压分别为(63.78 ± 6.89)mmHg、(73.23 ± 11.51)mmHg和(87.35 ± 10.92)mmHg。术后分别为(26.23 ± 10.27)mmHg、(93.48 ± 6.17)mmHg和(127.14 ± 13.15)mmHg,与治疗前比较差异均有统计学意义(P < 0.01)。随访6 ~ 36个月,25例疗效持续,1例复发。结论 肺动脉内导管碎栓联合局部灌注瑞替普酶溶栓治疗能迅速改善高危肺栓塞患者肺循环梗阻状况和临床症状,无明显并发症,对维持血流动力学稳定有很好作用。

参考文献/References:

[1] Raskob GE, Silverstein R, Bratzler DW, et al. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop[J]. Am J Prev Med, 2010, 38: S502 S509.
[2] Eid Lidt G, Gaspar J, Sandoval J, et al. Combined clot fragmentation and aspiration in patients with acute pulmonary embolism[J]. Chest, 2008, 134: 54 60.
[3] Tajima H, Murata S, Kumazaki T, et al. Manual aspiration thrombectomy with a standard PTCA guiding catheter for treatment of acute massive pulmonary thromboembolism[J]. Radiat Med, 2004, 22: 168 172.
[4] Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2008, 29: 2276 2315.
[5] 郭丹杰. 肺动脉血栓栓塞的挑战及诊治对策[J]. 临床药物治疗杂志, 2009, 7: 17 21.
[6] Jaff MR, Mcmurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association[J]. Circulation, 2011, 123: 1788 1830.
[7] 李圣青. 肺血栓栓塞症抗血栓治疗新进展[J]. 中国实用内科杂志, 2013, 33: 348 351.
[8] 刘 磊, 徐 克, 肖 亮. 肺动脉血栓栓塞的影像诊断新进展及介入治疗研究[J]. 介入放射学杂志, 2009, 18: 60 62.
[9] 瑞替普酶Ⅱ期临床试验协作组. 注射用瑞替普酶(派通欣)治疗急性心肌梗死有效性及安全性临床研究[J]. 中国心血管病研究杂志, 2004, 3: 171 174.
[10] 杨 明, 刘桂荣, 孙艳斌, 等. 第三代溶栓剂治疗大面积肺动脉栓塞的临床研究[J]. 中国医药导报, 2011, 8: 65 67.

相似文献/References:

[1]隋守光,王世礼,孙 鹏,等.瑞替普酶、尿激酶经导管溶栓治疗急性下肢深静脉血栓的疗效观察[J].介入放射学杂志,2013,(01):57.
 SUI Shou? guang,WANG Shi? li,SUN Peng,et al. Catheter- directed thrombolytic therapy with use of reteplase and urokinase for the treatment of acute deep venous thrombosis of lower extremity: an observation of clinical results[J].journal interventional radiology,2013,(10):57.

备注/Memo

备注/Memo:
(收稿日期:2014-04-06)
(本文编辑:李 欣)
更新日期/Last Update: 2014-10-21